Skip to content

Cold Plasma to Treat Hair Loss

Using Indirect Cold Atmospheric Pressure Plasma (Plasma Activate Liquid) for the Treatment of Hair Loss

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04379752
Enrollment
14
Registered
2020-05-07
Start date
2020-07-01
Completion date
2021-09-15
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic Alopecia

Brief summary

Self applied cold plasma activated medium used for androgenetic alopecia

Interventions

DEVICECold-atmospeheric pressure plasma activated aqueous-alcohol solution treatment

Cold plasma is generated and applied to carrier liquid. Subjects are provided with the liquid to apply to the treated area

Sponsors

Dr. Peter C. Friedman
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of mild-to moderate androgenetic alopecia * ability of applying treatment regularly * ability to keep in-person follow-up appointments

Exclusion criteria

* any inflammatory scalp condition * starting or discontinuing any hair loss treatments within 6 months of start date * allergy to any components of the carrier solution

Design outcomes

Primary

MeasureTime frameDescription
Presence of detectable hair growth3 months and 6 monthsPresence of hair growth is observed clinically. Evaluation may include photo comparison, hair count, trichoscopy

Secondary

MeasureTime frameDescription
Adverse effects related to the treatmentthroughout study completeion, 6 monthsPatients are monitored for adverse effects, including but not limited to irritation, itch, inflammation, scaling, redness, rash, peeling, blistering

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026